# Therapeuticsmd (TXMD) — Earnings

TXMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/txmd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2024 |
| Period end | Sep 30, 2024 |
| EPS actual | −$0.05 |
| EPS estimate | $0.04 |
| EPS surprise | −225.00% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $2.3M |
| Reported | Nov 12, 2024 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/25743/000121390024096811/ea0218728-10q_therapeutics.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2024 | Nov 12, 2024 | $0.04 | −$0.05 | -225.00% | $2.3M | — |
| Q2 2024 | Aug 12, 2024 | $0.03 | −$0.09 | -400.00% | $2.2M | — |
| Q1 2024 | May 10, 2024 | $0.03 | −$0.07 | -333.33% | $2.2M | — |
| Q4 2023 | Mar 29, 2024 | −$0.13 | −$0.13 | 0.00% | $600,000.00 | — |
| Q3 2023 | Nov 14, 2023 | −$0.15 | −$0.13 | 13.33% | $500,000.00 | — |
| Q2 2023 | Aug 14, 2023 | −$0.07 | −$0.24 | -242.86% | $500,000.00 | — |
| Q1 2023 | May 15, 2023 | $0.06 | −$0.24 | -500.00% | $1.7M | $400,000.00 |
| Q3 2022 | Nov 14, 2022 | −$0.57 | −$3.13 | -449.12% | $26.8M | $20.9M |
| Q2 2022 | Aug 15, 2022 | −$3.04 | $12.39 | 507.57% | $23.2M | $28.5M |
| Q1 2022 | May 16, 2022 | −$4.00 | −$5.69 | -42.25% | $18.0M | $18.9M |
| Q4 2021 | Mar 10, 2022 | −$3.83 | −$5.00 | -30.44% | $29.4M | $18.7M |
| Q3 2021 | Nov 12, 2021 | −$5.00 | −$5.50 | -10.00% | $25.9M | $24.5M |
| Q2 2021 | Aug 4, 2021 | −$5.50 | −$5.50 | 0.00% | $22.1M | $23.0M |
| Q1 2021 | May 6, 2021 | −$6.13 | −$5.50 | 10.20% | $19.8M | $19.6M |
| Q4 2020 | Mar 2, 2021 | −$5.30 | −$7.50 | -41.51% | $21.1M | $22.6M |
| Q3 2020 | Nov 9, 2020 | −$6.71 | −$6.00 | 10.64% | $15.5M | $19.3M |
| Q2 2020 | Aug 6, 2020 | −$8.31 | −$9.50 | -14.29% | $10.4M | $10.7M |
| Q1 2020 | May 6, 2020 | −$9.51 | −$10.50 | -10.44% | $11.4M | $12.3M |

## Frequently Asked Questions

### When did Therapeuticsmd (TXMD) last report earnings?

Therapeuticsmd last reported on Nov 12, 2024, covering fiscal Q3 2024.

### Did TXMD beat earnings estimates?

No. Therapeuticsmd reported EPS of −$0.05 for Q3 2024 against a $0.04 estimate — a 225.00% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).